These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 18799315)

  • 21. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products.
    Youngster SK; McKeown KA; Jin YZ; Ramsay RR; Heikkila RE; Singer TP
    J Neurochem; 1989 Dec; 53(6):1837-42. PubMed ID: 2809594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The structure-activity relationship in the dehydrogenation processes of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogs under the action of MAO].
    Sablin SO; Tkachenko SE; Bachurin SO
    Dokl Akad Nauk SSSR; 1991; 318(1):228-31. PubMed ID: 1893833
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on 4-benzyl-1-methyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Naiman N; Rollema H; Johnson E; Castagnoli N
    Chem Res Toxicol; 1990; 3(2):133-8. PubMed ID: 2130940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic isotope effects as probes of the mechanism of galactose oxidase.
    Whittaker MM; Ballou DP; Whittaker JW
    Biochemistry; 1998 Jun; 37(23):8426-36. PubMed ID: 9622494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Ottoboni S; Carlson TJ; Trager WF; Castagnoli K; Castagnoli N
    Chem Res Toxicol; 1990; 3(5):423-7. PubMed ID: 2133093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
    Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
    J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel and selective monoamine oxidase B substrate.
    Rimoldi JM; Puppali SG; Isin E; Bissel P; Khalil A; Castagnoli N
    Bioorg Med Chem; 2005 Oct; 13(20):5808-13. PubMed ID: 15993094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate specificity and kinetic isotope effect analysis of the Eschericia coli ketopantoate reductase.
    Zheng R; Blanchard JS
    Biochemistry; 2003 Sep; 42(38):11289-96. PubMed ID: 14503879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A
    FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates.
    Kalgutkar AS; Castagnoli K; Hall A; Castagnoli N
    J Med Chem; 1994 Apr; 37(7):944-9. PubMed ID: 8151621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stylbasole analogues of MPTP as monoamine oxidase (MAO) substrates.
    Sablin SO; Bachurin SO; Tkachenko SE
    J Neural Transm Suppl; 1990; 32():119-22. PubMed ID: 2089080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone.
    Yoshihara S; Ohta S
    Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N
    J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
    Singer TP; Salach JI; Castagnoli N; Trevor A
    Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures.
    Di Monte DA; Schipper HM; Hetts S; Langston JW
    Glia; 1995 Oct; 15(2):203-6. PubMed ID: 8567072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A.
    Miller JR; Edmondson DE
    Biochemistry; 1999 Oct; 38(41):13670-83. PubMed ID: 10521274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determinants in the bioactivation of the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Efange SM; Boudreau RJ
    J Comput Aided Mol Des; 1991 Oct; 5(5):405-17. PubMed ID: 1685185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Zang LY; Misra HP
    J Biol Chem; 1993 Aug; 268(22):16504-12. PubMed ID: 8393868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.